Brawn Biotech Ltd. - Research Center
530207 BRAWN Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
10.21 |
11.17 |
5.41 |
3.21 |
17.13 |
Operating profit |
-0.55 |
-0.16 |
-1.28 |
-0.72 |
-0.10 |
Interest |
- |
- |
0.01 |
0.06 |
0.01 |
Gross profit |
-0.55 |
-0.16 |
-1.38 |
-0.69 |
-0.11 |
EPS (Rs) |
-1.98 |
-0.74 |
-3.12 |
-2.36 |
-0.44 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
- |
- |
-0.09 |
0.09 |
- |
Stock adjustment |
1.06 |
0.04 |
-3.42 |
-1.04 |
-0.09 |
Raw material |
- |
0.05 |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.72 |
0.69 |
0.77 |
1.04 |
1.05 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
8.98 |
10.54 |
9.35 |
3.94 |
16.27 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.04 |
0.05 |
0.04 |
0.02 |
0.02 |
Taxation |
- |
0.01 |
-0.47 |
- |
- |
Net profit / loss |
-0.60 |
-0.22 |
-0.94 |
-0.71 |
-0.13 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
3.00 |
3.00 |
3.00 |
3.00 |
3.00 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-5.38 |
-1.43 |
-23.65 |
-22.61 |
-0.57 |
GPM (%) |
-5.39 |
-1.44 |
-25.82 |
-20.89 |
-.66 |
NPM (%) |
-5.83 |
-2.00 |
-17.59 |
-21.45 |
-0.76 |